Journal Basic Info

  • Impact Factor: 1.989**
  • H-Index: 6
  • ISSN: 2637-4625
  • DOI: 10.25107/2637-4625
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Gastroenterological Surgery
  •  Cardiac Surgery
  •  Reconstructive Surgery
  •  Vascular Surgery
  •  Ophthalmology
  •  Obstetrics & Gynecology
  •  Transplant Surgery
  •  Podiatric Surgery


Citation: World J Surg Surg Res. 2021;4(1):1300.DOI: 10.25107/2637-4625.1300

Performance of Aura Air™ Purification System against Anti-Infectious Bronchitis Virus (IBV)

Olga Klebanov1*, Vera Pavlov1, Eldar Shnaiderman2, Roei Friedberg2, Pitcovski J3, Vladimir Glukhman4 and Aviram Nissan1

1Department of General and Oncological Surgery-Surgery C, The Surgical Oncology Laboratory, The Chaim Sheba
Medical Center, Tel Hashomer, Ramat Gan, Israel
2Aura Smart Air Ltd., Tel Aviv, Israel
3The MIGAL Galilee Research Institute Ltd, Southern Industrial Zone, Tarshish St, Kiryat Shmona 11016, Israel
4Industrial Biology Expertise and Solutions, Com., Jerusalem, Israel

*Correspondance to: Olga Klebanov 

 PDF  Full Text Research Article | Open Access


The COVID-19 pandemic caused by the SARS-Co-V-2 novel coronavirus has had severe economic
and public health impacts worldwide. Public health officials have advocated for limiting indoor
activities, wearing masks in public, and hand washing to control the spread of the virus. Given the
closing of schools and businesses, teleworking, and public fear of contracting infections in indoor
spaces, in May 2020, Aura Air developed and tested a smart air device to potentially purify indoor
air of viral and other pathogenic particles. The company initiated a study with The Chaim Sheba
Medical Center to test the effectiveness of the smart air’s disinfection capabilities on the coronavirus
as part of our strategic, long-term collaboration. The study aimed to measure the device’s ability to
purify air contaminated by and to and inactivate anti-IBV (Infectious Bronchitis Virus), an avian
coronavirus that does not cause infections in humans and is similar in size to the SARS-CoV-2.
The system uses a multi-cascade air disinfection principle, and the study was performed in two
stages. The first stage tested each disinfection element's antiviral performance, and the second tested
the ability to disinfect virus-contaminated air environments by virus aerosol. Results showed that
each separate module within the filtration device had strong antiviral properties. Furthermore, the
filtration system effectively reduced virus amount in an aerosol contaminated environment in both
high and low aerosol concentrations. Together with vaccination programs and other measures to
limit viral spread, this device may allow for the reopening of global economies by providing some
measure of confidence that indoor air spaces are safe to resume normal activities.


Aura Air; Air purification; Multi-cascade air disinfection; Coronavirus

Cite the Article:

Klebanov O, Pavlov V, Shnaiderman E, Friedberg R, Pitcovski J, Glukhman V, et al. Performance of Aura Air™ Purification System against Anti-Infectious Bronchitis Virus (IBV). World J Surg Surgical Res. 2021; 4: 1300..

Search Our Journal

Journal Indexed In

Articles with Grants

Early Results of a Comparative Study of eHealth in Bariatric Surgery
 Abstract  PDF  Full Text
Analysis of SUVmax Metabolic Activity in Non-Small Cell Lung Cancer Depending on Selected Clinical and Pathomorphological Factors
 Abstract  PDF  Full Text
View More...